Elan Pharmaceuticals Selects Medidata Solutions, Inc. Rave(R) to Support Clinical Development Activities

Medidata Solutions today announced that Elan Pharmaceuticals, Inc. has selected Medidata Rave as its electronic data capture (EDC), management and reporting solution. Elan plans to begin using Rave in mid- and late-stage clinical studies in North America.
MORE ON THIS TOPIC